Skip to main content
. 2022 Apr 5;35(5):1109–1118. doi: 10.1111/jar.12996

TABLE 4.

Consumption of each type of psychotropic medication according to the presence of each mental health condition and behavioural problems

Mental health condition Anxiolytics N = 181 (18.3%) Antidepressants N = 187 (18.9%) Antipsychotics N = 274 (27.6%) None N = 611 (89.3%)
n % n % n % n %
Destructive disorders 62 34.3 58 31.0 100 36.4 42 6.9
Anxiety disorders 66 36.4 56 29.9 71 25.9 38 6.2
Depressive disorders 51 28.1 81 43.3 70 25.5 39 6.3
Schizophrenia spectrum disorders 47 25.9 42 22.5 83 30.2 9 1.5
Obsessive–compulsive disorders 23 12.7 37 19.8 42 15.3 26 4.2
Sleeping disorders 32 17.6 23 12.3 38 13.8 24 3.9
Personality disorders 14 7.7 22 11.8 22 8.0 10 1.6
Dementia/AD 9 4.9 14 7.5 18 6.5 20 3.3
Bipolar disorders 16 8.8 20 10.7 27 9.8 4 .6
Eating disorders 8 4.4 13 7.0 18 6.5 9 1.5
Excretion disorders 10 5.5 5 2.7 11 4.0 10 1.6
Addictive disorders 2 1.1 4 2.1 5 1.8 6 .9
Dissociative disorders 2 1.1 4 2.1 7 2.5 1 .2
Other mental health condition 6 3.3 6 3.2 7 2.5 5 .8
No mental health condition 32 17.7 27 14.4 50 18.2 464 75.9
Behavioural problems Anxiolytics N = 181 (18.3%) Antidepressants N = 187 (18.9%) Antipsychotics N = 274 (27.6%) None N = 611 (89.3%)
N % N % N % N %
Stereotyped behaviour 77 42.5 71 38.0 103 37.5 122 19.9
Aggressive behaviour 73 40.3 76 40.6 116 42.3 92 15.1
Disruptive behaviour 69 38.1 71 38.0 104 37.9 74 12.1
Socially offensive behaviour 37 20.4 41 21.9 57 20.8 37 6.1
Self‐injury behaviour 29 16.0 26 13.9 38 13.8 32 5.2
Other challenging behaviour 12 6.6 12 6.4 14 5.1 17 2.8
No behavioural problem 39 21.5 45 24.1 63 22.9 351 57.4